Members |
targetComponentId |
Infection by Grahamella peromysci |
Infection by Bartonella peromysci |
Infection by Leishmania tropica major |
Dry form of cutaneous leishmaniasis |
Infection by Microsporea |
Infection by Microspora |
infektion orsakad av Microsporida |
Infection by Microsporidia |
infektion orsakad av Monosporium apiospermum |
Infection by Scedosporium boydii |
infektion orsakad av Pneumocystis carinii |
Infection by Pneumocystis jirovecii |
Infection by Rudimicrosporea |
Mycosis |
Infection by other schistosoma |
Infection by Schistosoma |
infektion specificerad, efter lokalisation |
Disorder due to infection |
infektion orsakad av Armillifer grandi |
Infection caused by Armillifer grandis |
infektion orsakad av Bicaulus |
Infection by Varestrongylus |
infektion orsakad av Escherichia coli 0158 |
Infection caused by Escherichia coli O158 |
infektion orsakad av Madurella mycetomii |
Infection caused by Madurella mycetomatis |
infektion orsakad av Oesophagostomum radiatium |
Infection caused by Oesophagostomum radiatum (disorder) |
Infection due to Mycobacterium aquae |
Infection due to Mycobacterium gordonae |
Infection due to Penicillium chrysogenum |
Infection caused by Penicillium chrysogenum (disorder) |
Infection due to Penicillium mycetogenum |
Infection due to Penicillium mycetomagenum |
Infection due to Penicillium patulum |
Infection due to Penicillium griseofulvum |
Infection due to Penicillium rubrum |
Infection due to Penicillium purpurogenum |
Infection due to other mycobacteria, NOS |
Mycobacteriosis |
Infection of bone, NEC |
Infection of bone |
Infection of meibomian gland |
Internal hordeolum (disorder) |
Infection specific to the perinatal period |
Neonatal infectious disorder |
Infectious bursal disease virus |
Infectious bursal disease virus |
körtelfeber med pneumoni |
Viral pneumonia due to infectious mononucleosis caused by human herpesvirus 4 (disorder) |
Infectious pancreatic necrosis virus of fish |
Infectious pancreatic necrosis virus of fish |
infektiös dermatit samtidig med och orsakad av infektion med humant T-lymfotropt virus 1 |
Infective dermatitis associated with human T-cell lymphotropic virus 1 infection (disorder) |
Infective necrosis of pancreas |
Necrosis of pancreas |
nedre delen av os ilium |
Inferior innominate shear (finding) |
Infestation by Hypodermatidae |
Infestation by Hypodermatinae |
angrepp av Ornithodorus |
Infestation caused by Ornithodoros (disorder) |
Inflammatory and infective disease of the central nervous system |
Inflammatory AND/OR infective disease of the central nervous system (navigational concept) |
Infliximab 100mg/vial injection |
Infliximab 100 mg powder for solution for injection vial |
Infliximab 100mg/vl injection |
Infliximab 100 mg powder for solution for injection vial |
Influenza due to other Influenza virus |
Influenza |
biverkning av ytantigenvaccin mot influensa |
Adverse reaction to influenza virus vaccine |
influensavaccination, kallelse per telefon |
Invitation by telephone for influenza vaccination (procedure) |
Influenza vaccine adverse reaction |
Adverse reaction to influenza virus vaccine |
Infrakingdom Discristata |
Infrakingdom Discicristata |
läkemedelsform för inhalation |
Pulmonary dose form (dose form) |
allergi mot inhalerad isoprenalin |
Allergy to isoprenaline |
ärftlig predisposition för essentiell trombocytemi |
Essential thrombocythemia (disorder) |
Initard insulin adverse reaction |
Insulin adverse reaction |
Initard insulin allergy |
Allergy to insulin |
injicerbart plasmin |
Bovine fibrinogen |
Injectable interferon |
Interferon |
injektion av Sandoglobulin |
Injection of normal human immunoglobulin |
Injection of Sandoglobulin |
Injection of normal human immunoglobulin |
Injection of anesthetic agent into uterine paracervical nerve |
Paracervical block anesthesia |
Injection of ankle |
Injection of joint of ankle |
Injection of spinal canal |
Intrathecal injection |
Injection of tendon |
Injection of tendon sheath |
Injection of therapeutic substance |
Injection of therapeutic agent |
Injection of vein |
Intravenous injection |
reaktion på injektionsställe |
Injection site disorder |
Injection therapy |
Injection - action |
Injury at C1-C4 level with other specified spinal cord injury and without bone injury |
Injury at C1-C4 level with spinal cord injury AND without bone injury |
Injury at C5-C7 level with other specified spinal cord injury and without bone injury |
Injury at C5-C7 level with spinal cord injury AND without bone injury |
Injury of hand, except finger |
Injury of hand |
Injury of neck including whiplash |
Injury of neck |
Injury of nerve roots AND/OR spinal plexus |
Injury of peripheral nerve (disorder) |
Injury of other specified branch of celiac axis, NEC |
Injury of branch of celiac axis |
Injury of peripheral nerve of pelvic girdle AND/OR lower limb |
Injury of peripheral nerve (disorder) |
Injury of peripheral nerve of shoulder girdle AND/OR upper limb |
Injury of peripheral nerve (disorder) |
Injury of portal AND/OR splenic veins |
Injury of vein |
inositolnikotinatallergi |
Allergy to inositol |
inläggning av Baerveldtventil i främre ögonkammare |
Insertion of drainage tube into anterior chamber |
insättning av peritoneovenös Denvershunt |
Insertion of peritoneovenous shunt |
insättning av Le Veenshunt |
Insertion of peritoneovenous shunt |
insättning av Norplant |
Insertion of subcutaneous contraceptive (procedure) |
inläggning av biventrikulär permanent pacemaker under röntgengenomlysning |
Implantation of cardiac biventricular permanent pacemaker using fluoroscopic guidance |
Insertion of catheter in anterior chamber of eye for permanent drainage in glaucoma |
Insertion of drainage tube into anterior chamber |
Insertion of extravascular umbrella of inferior vena cava, complete |
Insertion of intravascular umbrella of inferior vena cava, complete |
Insertion of extravascular umbrella of inferior vena cava, partial |
Insertion of intravascular umbrella of inferior vena cava, partial |
inläggning av permanent pacemaker under röntgengenomlysning |
Implantation of permanent cardiac pacemaker using fluoroscopic guidance (procedure) |
Insertion of silicon plug |
Insertion - action (qualifier value) |
Inspection - physical examination - action (qualifier value) |
Inspection - action |
Instrumental insertion |
Insertion - action (qualifier value) |
Instrumentation - action |
Action |
insufflator av typ 2-plast |
Plastic insufflator (physical object) |
insufflator av typ 4-plast |
Plastic insufflator (physical object) |
bovint insulinextrakt |
Beef insulin-containing product |
humant insulinextrakt |
Human insulin-containing product |
porcint insulinextrakt |
Pork insulin-containing product |
Insulin antibody |
Anti-insulin antibody |
bifasiskt humant isofaninsulin 10/90, 100 E/ml, injektionsvätska, lösning, cylinderampull 1,5 ml |
Product containing precisely salmon calcitonin 200 unit/1 actuation conventional release nasal spray (clinical drug) |
bifasiskt humant isofaninsulin 10/90, 100 E/ml, injektionsvätska, lösning, cylinderampull 3 ml |
Product containing precisely salmon calcitonin 200 unit/1 actuation conventional release nasal spray (clinical drug) |
bifasiskt humant isofaninsulin 10/90, 100 E/ml, injektionsvätska, lösning, förfylld penna 3 ml |
Product containing precisely salmon calcitonin 200 unit/1 actuation conventional release nasal spray (clinical drug) |
bifasiskt humant isofaninsulin 15/85, 100 E/ml, injektionsvätska, lösning, cylinderampull 3 ml |
Product containing precisely human isophane insulin 85 unit/1 milliliter and recombinant human regular insulin 15 unit/1 milliliter conventional release suspension for injection (clinical drug) |
bifasiskt humant isofaninsulin 15/85, 100 E/ml, injektionsvätska, lösning, förfylld penna 3 ml |
Product containing precisely human isophane insulin 85 unit/1 milliliter and recombinant human regular insulin 15 unit/1 milliliter conventional release suspension for injection (clinical drug) |
bifasiskt humant isofaninsulin 15/85, 100 E/ml, injektionsvätska, lösning, flaska 5 ml |
Product containing precisely human isophane insulin 85 unit/1 milliliter and recombinant human regular insulin 15 unit/1 milliliter conventional release suspension for injection (clinical drug) |
bifasiskt humant isofaninsulin 20/80, 100 E/ml, injektionsvätska, lösning, cylinderampull 1,5 ml |
Product containing precisely human isophane insulin 80 unit/1 milliliter and recombinant human regular insulin 20 unit/1 milliliter conventional release suspension for injection (clinical drug) |
bifasiskt humant isofaninsulin 20/80, 100 E/ml, injektionsvätska, lösning, cylinderampull 3 ml |
Product containing precisely human isophane insulin 80 unit/1 milliliter and recombinant human regular insulin 20 unit/1 milliliter conventional release suspension for injection (clinical drug) |
bifasiskt humant isofaninsulin 20/80, 100 E/ml, injektionsvätska, lösning, förfylld penna 3 ml |
Product containing precisely human isophane insulin 80 unit/1 milliliter and recombinant human regular insulin 20 unit/1 milliliter conventional release suspension for injection (clinical drug) |
bifasiskt humant isofaninsulin 25/75, 100 E/ml, injektionsvätska, lösning, cylinderampull 3 ml |
Product containing precisely human isophane insulin 75 unit/1 milliliter and recombinant human regular insulin 25 unit/1 milliliter conventional release suspension for injection (clinical drug) |
bifasiskt humant isofaninsulin 25/75, 100 E/ml, injektionsvätska, lösning, förfylld penna 3 ml |
Product containing precisely human isophane insulin 75 unit/1 milliliter and recombinant human regular insulin 25 unit/1 milliliter conventional release suspension for injection (clinical drug) |
bifasiskt humant isofaninsulin 25/75, 100 E/ml, injektionsvätska, lösning, flaska 5 ml |
Product containing precisely human isophane insulin 75 unit/1 milliliter and recombinant human regular insulin 25 unit/1 milliliter conventional release suspension for injection (clinical drug) |
bifasiskt humant isofaninsulin 30/70, 100 E/ml, injektionsvätska, lösning, cylinderampull 1,5 ml |
Product containing precisely human isophane insulin 70 unit/1 milliliter and recombinant human regular insulin 30 unit/1 milliliter conventional release solution for injection (clinical drug) |
bifasiskt humant isofaninsulin 30/70, 100 E/ml, injektionsvätska, lösning, flaska 10 ml |
Product containing precisely human isophane insulin 70 unit/1 milliliter and recombinant human regular insulin 30 unit/1 milliliter conventional release solution for injection (clinical drug) |
bifasiskt humant isofaninsulin 30/70, 100 E/ml, injektionsvätska, lösning, förfylld penna 3 ml |
Product containing precisely human isophane insulin 70 unit/1 milliliter and recombinant human regular insulin 30 unit/1 milliliter conventional release solution for injection (clinical drug) |
bifasiskt humant isofaninsulin 40/60, 100 E/ml, injektionsvätska, lösning, cylinderampull 1,5 ml |
Product containing precisely human isophane insulin 60 unit/1 milliliter and recombinant human regular insulin 40 unit/1 milliliter conventional release suspension for injection (clinical drug) |